Schedule of basic and diluted net loss per share |
Schedule of basic and diluted net loss per share |
|
|
|
|
|
|
|
|
|
|
Three Months Ended
March 31,
|
|
|
|
2023 |
|
|
2022 |
|
Numerator: |
|
|
|
|
|
|
Net loss |
|
$ |
(20,889 |
) |
|
|
(29,738 |
) |
|
|
|
|
|
|
|
|
|
Denominator - basic and diluted: |
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
74,473,741 |
|
|
|
72,335,952 |
|
|
|
|
|
|
|
|
|
|
Loss per share - basic and diluted |
|
$ |
(0.28 |
) |
|
|
(0.41 |
) |
|
Schedule of basic and diluted net loss per share |
|
|
|
|
|
|
|
|
|
|
Years Ended December 31, |
|
|
|
2022 |
|
|
2021 |
|
Numerator: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(85,382 |
) |
|
$ |
(70,526 |
) |
|
|
|
|
|
|
|
|
|
Denominator – basic and diluted: |
|
|
|
|
|
|
|
|
Weighted average common shares outstanding |
|
|
72,782,773 |
|
|
|
64,509,718 |
|
|
|
|
|
|
|
|
|
|
Net loss per share – basic and diluted |
|
$ |
(1.17 |
) |
|
$ |
(1.09 |
) |
|
Schedule of anti-dilutive net loss per share |
Schedule of anti-dilutive net loss per share |
|
|
|
|
|
|
|
|
|
|
March 31, |
|
|
|
2023 |
|
|
2022 |
|
Stock options outstanding |
|
|
7,766,234 |
|
|
|
6,144,473 |
|
Non-vested shares of restricted stock |
|
|
3,830,932 |
|
|
|
3,970,385 |
|
Warrants(a)
|
|
|
21,145,000 |
|
|
|
21,145,000 |
|
Convertible notes(a)
|
|
|
9,729,163 |
|
|
|
9,729,163 |
|
(a) |
The Convertible Notes and warrants referred to in Notes 10 and 13 were also excluded on an as converted basis because their effect would have been anti-dilutive. |
|
Schedule of anti-dilutive net loss per share |
|
|
|
|
|
|
|
|
|
|
December 31, |
|
|
|
2022 |
|
|
2021 |
|
Stock options outstanding(a)
|
|
|
7,812,178 |
|
|
|
5,489,492 |
|
Non-vested RSUs and RSAs |
|
|
4,267,746 |
|
|
|
3,314,715 |
|
Warrants(b)
|
|
|
- |
|
|
|
- |
|
Convertible Notes(b)
|
|
|
- |
|
|
|
- |
|
(a) |
If the Company had reported net income, the calculation of these per share amounts would have included the dilutive effect of these Common Stock equivalents using the treasury stock method for stock options. |
(b) |
The Convertible Notes and Warrants referred to in Notes 13 and 17, respectively, were also excluded on an as converted basis because their effect would have been anti-dilutive. |
|